Low bone mineral density is associated with dyslipidemia in South Korean men: The 2008-2010 Korean National Health and Nutrition Examination Survey

Endocrine Journal

Volumn 60, Issue 10, 2013, Pages 1179-1189

  Kim, Yang Hyun ^a   Nam, Ga Eun ^a   Cho, Kyung Hwan ^a   Choi, Youn Seon ^a   Kim, Seon Mee ^a   Han, Byung Duck ^a   Han, Kyung Do ^b   Lee, Kyung Shik ^c   Park, Chang Hae ^d   Kim, Do Hoon ^a  

^a Korea University College of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

^d Eulji University   (South Korea)

Author keywords

Atherosclerosis; Bone mineral density (BMD); Dyslipidemia; Osteoporosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; MALE; OSTEOPOROSIS; SOUTH KOREA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; REPUBLIC OF KOREA; TRIGLYCERIDES;

EID: 84886991755     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0224     Document Type: Article

References (54)

1. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
2. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213-219.
3. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, et al. (2003) Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139: 802-809.
4. Dobiasova M, Frohlich J (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL). Clin Biochem 34: 583-588.
5. Jia L, Long S, Fu M, Yan B, Tian Y, et al. (2006) Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses. Metabolism 55: 1141-1148.
6. Barzi F, Patel A, Woodward M, Lawes CM, Ohkubo T, et al. (2005) A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol 15: 405-413.
7. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96: 2520-2525.
8. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F (2001) Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med 161: 361-366.
9. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, et al. (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25: 50-57.
10. Mussolino ME, Gillum RF (2006) Bone mineral density and hypertension prevalence in postmenopausal women: results from the Third National Health and Nutrition Examination Survey. Ann Epidemiol 16: 395-399.
11. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, et al. (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20: 1912-1920.
12. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, et al. (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15: 389-395.
13. Samelson EJ, Kiel DP, Broe KE, Zhang Y, Cupples LA, et al. (2004) Metacarpal cortical area and risk of coronary heart disease: the Framingham Study. Am J Epidemiol 159: 589-595.
14. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE (1996) Vitamin K status and bone mass in women with and without aortic atherosclerosis: a populationbased study. Calcif Tissue Int 59: 352-356.
15. Tanko LB, Bagger YZ, Christiansen C (2003) Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73: 15-20.
16. Koshiyama H, Wada Y, Nakamura Y (2001) Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus. Arch Intern Med 161: 1678.
17. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, et al. (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49: 211-217.
18. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, et al. (2001) Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16: 182-188.
19. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, et al. (2004) Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 74: 136-142.
20. Solomon DH, Avorn J, Canning CF, Wang PS (2005) Lipid levels and bone mineral density. Am J Med 118: 1414.
21. Lee MH, Kim HC, Ahn SV, Hur NW, Choi DP, et al. (2012) Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J 36: 43-55.
22. Choi HJ, Shin CS, Ha YC, Jang S, Jang S, et al. (2012) Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 30: 54-58.
23. Kim HY, Choe JW, Kim HK, Bae SJ, Kim BJ, et al. (2010) Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int 86: 350-358.
24. Go JH, Song YM, Park JH, Park JY, Choi YH (2012) Association between Serum Cholesterol Level and Bone Mineral Density at Lumbar Spine and Femur Neck in Postmenopausal Korean Women. Korean J Fam Med 33: 166-173.
25. Hagströmer M, Oja P, Sjöström M (2006) The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 9: 755-762.
26. Park H, Kim K (2012) Association of alcohol consumption with lipid profile in hypertensive men. Alcohol Alcohol 47: 282-287.
27. Hanak V, Munoz J, Teague J, Stanley A, Jr., Bittner V (2004) Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol 94: 219-222.
28. Brownbill RA, Ilich JZ (2006) Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Womens Health (Larchmt) 15: 261-270.
29. Sivas F, Alemdaroǧlu E, Elverici E, Kuluǧ T, Kulug T, et al. (2009) Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int 29: 885-890.
30. Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19: 1105-1112.
31. Cui LH, Shin MH, Chung EK, Lee YH, Kweon SS, et al. (2005) Association between bone mineral densities and serum lipid profiles of pre-and post-menopausal rural women in South Korea. Osteoporos Int 16: 1975-1981.
32. Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, et al. (2003) Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res 29: 317-325.
33. Maruyama C, Imamura K, Teramoto T (2003) Assessment of LDL particle size by triglyceride/HDLcholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 10: 186-191.
34. Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228.
35. Prospective Studies C, Lewington S, Whitlock G, Clarke R, Sherliker P, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a metaanalysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370: 1829-1839.
36. Emerging Risk Factors C, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, et al. (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302: 1993-2000.
37. Tremollieres F, Ribot C (2010) Bone mineral density and prediction of non-osteoporotic disease. Maturitas 65: 348-351.
38. Fiore CE, Pennisi P, Pulvirenti I, Francucci CM (2009) Bisphosphonates and atherosclerosis. J Endocrinol Invest 32: 38-43.
39. Graham LS, Tintut Y, Parhami F, Kitchen CM, Ivanov Y, et al. (2010) Bone density and hyperlipidemia: the T-lymphocyte connection. J Bone Miner Res 25: 2460-2469.
40. Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, et al. (2008) Increased bone turnover in patients with hypercholesterolemia. Endocr J 55: 143-151.
41. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, et al. (1999) Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14: 2067-2078.
42. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, et al. (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680-687.
43. Tintut Y, Morony S, Demer LL (2004) Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 24: e6-10.
44. Celiloglu M, Aydin Y, Balci P, Kolamaz T (2009) The effect of alendronate sodium on carotid artery intimamedia thickness and lipid profile in women with postmenopausal osteoporosis. Menopause 16: 689-693.
45. Adami S, Braga V, Guidi G, Gatti D, Gerardi D, et al. (2000) Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J Bone Miner Res 15: 599-604.
46. Gerdes LU, Vestergaard P, Hermann AP, Mosekilde L (2001) Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women. J Bone Miner Res 16: 1906-1916.
47. Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, et al. (2004) Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19: 1619-1627.
48. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314.
49. Kokubu C, Heinzmann U, Kokubu T, Sakai N, Kubota T, et al. (2004) Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 131: 5469-5480.
50. Mani A, Radhakrishnan J, Wang H, Mani MA, Nelson-Williams C, et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278-1282.
51. Langer C, Gansz B, Goepfert C, Engel T, Uehara Y, et al. (2002) Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun 296: 1051-1057.
52. Haffner SM, Mykkanen L, Valdez RA, Katz MS (1993) Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab 77: 1610-1615.
53. Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G, Kaufman JM (2003) Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middleaged men. Atherosclerosis 166: 95-102.
54. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, et al. (2004) Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110: 2678-2686.